{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T08:06:26Z","timestamp":1789200386079,"version":"build-2803163510"},"reference-count":56,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T00:00:00Z","timestamp":1789171200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T00:00:00Z","timestamp":1789171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer Inc","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Vaccines"],"published-print":{"date-parts":[[2026,12,31]]},"DOI":"10.1080\/14760584.2026.2725347","type":"journal-article","created":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T07:41:26Z","timestamp":1789198886000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Clinical and economic impact of bivalent respiratory syncytial virus prefusion F (RSVpreF) vaccination in older adults: a cost-effectiveness analysis for Chile"],"prefix":"10.1080","volume":"25","author":[{"given":"Rafael","family":"Bolanos","sequence":"first","affiliation":[{"name":"Pfizer Value & Evidence Andean Cluster","place":["Lima, Peru"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas Eduardo","family":"Abbott","sequence":"additional","affiliation":[{"name":"Pfizer Value & Evidence Andean Cluster","place":["Santiago, Chile"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Shajarizadeh","sequence":"additional","affiliation":[{"name":"Evidinno Outcomes Research","place":["Vancouver, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nishu","family":"Gaind","sequence":"additional","affiliation":[{"name":"Evidinno Outcomes Research","place":["Vancouver, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramandeep","family":"Kaur","sequence":"additional","affiliation":[{"name":"Evidinno Outcomes Research","place":["Vancouver, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luka","family":"Ivkovic","sequence":"additional","affiliation":[{"name":"Evidinno Outcomes Research","place":["Vancouver, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Francisco","family":"Falconi","sequence":"additional","affiliation":[{"name":"Pfizer Vaccines Medical and Scientific Affairs","place":["Santiago, Chile"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rengina","family":"Kefalogianni","sequence":"additional","affiliation":[{"name":"Pfizer UK","place":["Tadworth, Surrey, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dino","family":"Sepulveda","sequence":"additional","affiliation":[{"name":"Universidad del Desarrollo","place":["Santiago, Chile"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Mendes","sequence":"additional","affiliation":[{"name":"Pfizer UK","place":["Tadworth, Surrey, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,9,12]]},"reference":[{"key":"e_1_3_7_2_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268820000400"},{"key":"e_1_3_7_3_1","doi-asserted-by":"publisher","DOI":"10.3390\/idr16040057"},{"key":"e_1_3_7_4_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0324735"},{"key":"e_1_3_7_5_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2024.2381298"},{"key":"e_1_3_7_6_1","unstructured":"CAVEI. Recomendaci\u00f3n del CAVEI sobre incorporaci\u00f3n de vacunaci\u00f3n contra virus respiratorio sincicial en adultos mayores y embarazadas en el Programa Nacional de Inmunizaciones [Cavei Recommendation on Vaccination Incorporation Against Respiratory Syncytial Virus in Older Adults and Pregnant Women in The National Immunization Program]. 2023. Available from: https:\/\/www.nitag-resource.org\/sites\/default\/files\/2024-01\/Recomendacion-del-CAVEI-sobre-incorporacion-de-vacunacion-contra-virus-respiratorio-sincicial-en-adultos-mayores-y-embarazadas-1.pdf"},{"key":"e_1_3_7_7_1","unstructured":"Ministerio de Salud. Abrysvo: Folleto de informaci\u00f3n al profesional [Abrysvo: professional information brochure]. 2024. Available from: https:\/\/www.ispch.gob.cl\/folleto\/abrysvo-liofilizado-para-solucion-inyectable-con-solvente\/"},{"key":"e_1_3_7_8_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2213836"},{"key":"e_1_3_7_9_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2024.2436183"},{"key":"e_1_3_7_10_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines12111232"},{"key":"e_1_3_7_11_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.15245"},{"key":"e_1_3_7_12_1","unstructured":"Instituto Nacional de Estadisticas. Proyecciones de poblaci\u00f3n [Population Projections]. 2025. Available from: https:\/\/www.ine.gob.cl\/estadisticas\/sociales\/demografia-y-vitales\/proyecciones-de-poblacion"},{"key":"e_1_3_7_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-023-00904-z"},{"key":"e_1_3_7_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2025.103292"},{"key":"e_1_3_7_15_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofae631.2508"},{"key":"e_1_3_7_16_1","unstructured":"Instituto de Salud Publica. Informe de Circulaci\u00f3n de Virus Respiratorios 2024 [Respiratory virus circulation report 2024]. Available from: https:\/\/www.ispch.cl\/biomedico\/vigilancia-de-laboratorio\/ambitos-de-vigilancia\/vigilancia-virus-respiratorios\/informes-virus-respiratorios\/?y=2024"},{"key":"e_1_3_7_17_1","unstructured":"Instituto Nacional de Estadisticas. Estad\u00edsticas vitales - 2023 [Vital statistics - 2023]. Available from: https:\/\/www.ine.gob.cl\/estadisticas\/sociales\/demografia-y-vitales\/nacimientos-matrimonios-y-defunciones"},{"key":"e_1_3_7_18_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir955"},{"key":"e_1_3_7_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2021.106476"},{"key":"e_1_3_7_20_1","doi-asserted-by":"crossref","unstructured":"Tartof SY Aliabadi N Pharm EZ et al. Vaccine effectiveness of bivalent RSVpreF against hospitalization or emergency department visits for respiratory syncytial virus-related respiratory illness across two RSV seasons at a large integrated US healthcare network. 2025.","DOI":"10.2139\/ssrn.5803145"},{"key":"e_1_3_7_21_1","unstructured":"Ministerio de Salud. Campa\u00f1a influenza 2025 [2025 Influenza campaign]. Available from: https:\/\/informesdeis.minsal.cl\/SASVisualAnalytics\/?reportUri=%2Freports%2Freports%2Ff7beae19-0ab8-44dd-b26e-89a481315afb\u00a7ionIndex=0&sso_guest=true&sas-welcome=false"},{"key":"e_1_3_7_22_1","unstructured":"Ministerio de Salud. Campa\u00f1a vacunaci\u00f3n Influenza 2024 [2024 Influenza campaign]. Available from: https:\/\/informesdeis.minsal.cl\/SASVisualAnalytics\/?reportUri=%2Freports%2Freports%2F5c66d9f7-45dd-4017-900d-5a0625186997\u00a7ionIndex=0&sso_guest=true&reportViewOnly=true&reportContextBar=false&sas-welcome=false"},{"key":"e_1_3_7_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2011.09.002"},{"key":"e_1_3_7_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/irv.12903"},{"key":"e_1_3_7_25_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiac069"},{"key":"e_1_3_7_26_1","unstructured":"FONASA. Datos abierto 2024. 2024. Available from: https:\/\/www.fonasa.cl\/sites\/fonasa\/datos-abiertos\/bases-grd"},{"key":"e_1_3_7_27_1","unstructured":"Ministerio de Salud. Departamento de Econom\u00eda de la Salud. Estudio Verificaci\u00f3n del Costo Esperado Individual Promedio por Beneficiario del Conjunto Priorizado de Problemas de Salud con Garant\u00edas Expl\u00edcitas (EVC-2021). 2025."},{"key":"e_1_3_7_28_1","unstructured":"FONASA. Chilean 2024 Public Tarrif: Tarifario Modalidad Atencion Institucional. 2025. Available from: https:\/\/nuevo.fonasa.gob.cl\/sites\/fonasa\/adjuntos\/2ArancelMAI2024"},{"key":"e_1_3_7_29_1","unstructured":"Ministerio de Salud. Gu\u00eda metodol\u00f3gica para la evaluaci\u00f3n econ\u00f3mica de intervenciones en salud en Chile [Methodological Guide for the Economic Evaluation of Health Interventions in Chile]. 2013. Available from: https:\/\/www.orasconhu.org\/case\/sites\/default\/files\/files\/EE_FINAL_web.pdf"},{"key":"e_1_3_7_30_1","unstructured":"Ministerio del Trabajo y Prevision Social. Tasa de participaci\u00f3n nacional y regional seg\u00fan tramo etario [National and regional participation rate by age group]. 2025. Available from: https:\/\/de.ine.gob.cl\/vis?df[ds]=ds-lmis-605release&df[id]=DF_TP_EDAD&df[ag]=CL01&df[vs]=1.0&pd=2018-01%2C2024-60609&dq=M.._T.&ly[cl]=EDAD&ly[rw]=TIME_PERIOD&to[TIME_PERIOD]=false&vw=tb"},{"key":"e_1_3_7_31_1","doi-asserted-by":"publisher","DOI":"10.26633\/rpsp.2019.1"},{"key":"e_1_3_7_32_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7339a1"},{"key":"e_1_3_7_33_1","unstructured":"Ministerio de Salud. Chile national health survey 2016\u20132017. Available from: https:\/\/epi.minsal.cl\/bases-de-datos\/"},{"key":"e_1_3_7_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.02.013"},{"key":"e_1_3_7_35_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaf310"},{"key":"e_1_3_7_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(25)00546-8"},{"key":"e_1_3_7_37_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2025.15896"},{"key":"e_1_3_7_38_1","unstructured":"Ministerio de Salud. Cobertura Nacional de Inmunizaciones a\u00f1o 2024 Informe (Preliminar). 2025. Available from: https:\/\/vacunas.minsal.cl\/wp-content\/uploads\/2025\/09\/Informe-de-Coberturas_2024_enero_diciembre_preliminar.pdf"},{"key":"e_1_3_7_39_1","unstructured":"International Monetary Fund. GDP per capita current prices U.S. dollars per capita. 2025 [cited 2025 Oct 20]. Available from: https:\/\/www.imf.org\/external\/datamapper\/NGDPDPC@WEO\/CHN\/HKG\/JPN\/KOR\/SGP\/TWN"},{"key":"#cr-split#-e_1_3_7_40_1.1","unstructured":"World Health Organization [Internet]. Macroeconomics and health: investing in health for economic development: executive summary \/ report of the commission on macroeconomics and health Geneva. 2001 [updated 2024 Jun 4"},{"key":"#cr-split#-e_1_3_7_40_1.2","unstructured":"cited 2024 Oct 10]. Available from: https:\/\/iris.who.int\/bitstream\/handle\/10665\/42463\/a74868.pdf?sequence=1&isAllowed=y"},{"key":"e_1_3_7_41_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-024-01012-2"},{"key":"e_1_3_7_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2024.02.041"},{"key":"e_1_3_7_43_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40266-015-0258-9"},{"key":"e_1_3_7_44_1","doi-asserted-by":"publisher","DOI":"10.1007\/s41030-024-00253-3"},{"key":"e_1_3_7_45_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.56767"},{"key":"e_1_3_7_46_1","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0160-2025"},{"key":"e_1_3_7_47_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2025.15405"},{"key":"e_1_3_7_48_1","doi-asserted-by":"publisher","DOI":"10.14745\/ccdr.v51i23a01"},{"key":"e_1_3_7_49_1","volume-title":"Advisory Committee on Immunization Practices (ACIP) Meeting","author":"Ortega-Sanchez IR","year":"2023","unstructured":"Ortega-Sanchez IR. Economics of vaccinating U.S. adults \u226560 years-old against respiratory syncytial virus. In: Advisory Committee on Immunization Practices (ACIP) Meeting; Atlanta, GA, USA. Centers for Disease Control and Prevention; 2023."},{"key":"e_1_3_7_50_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11101605"},{"key":"e_1_3_7_51_1","volume-title":"RSVVW\u201924","author":"Li Y","year":"2024","unstructured":"Li Y, Kenmoe S, Begier E, et al. Respiratory syncytial virus (RSV) disease burden among adults in primary care settings in high\u2013income countries: a systematic review and modelling study. In: RSVVW\u201924; Mumbai, India. ReSViNET; 2024."},{"key":"e_1_3_7_52_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciad707"},{"key":"e_1_3_7_53_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy991"},{"key":"e_1_3_7_54_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaf186"},{"key":"e_1_3_7_55_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiaa361"},{"key":"e_1_3_7_56_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-024-00974-7"}],"container-title":["Expert Review of Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14760584.2026.2725347","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/14760584.2026.2725347","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14760584.2026.2725347","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T07:41:35Z","timestamp":1789198895000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14760584.2026.2725347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,12]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12,31]]}},"alternative-id":["10.1080\/14760584.2026.2725347"],"URL":"https:\/\/doi.org\/10.1080\/14760584.2026.2725347","relation":{},"ISSN":["1476-0584","1744-8395"],"issn-type":[{"value":"1476-0584","type":"print"},{"value":"1744-8395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,12]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierv20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierv20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-01-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-23","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2725347"}}